Compare PhaseRx (330) vs. Competitors

0 Followers

Comparison Results

330

PhaseRx

―

€11.00

―

―

Scinai Immunotherapeutics

$2.87

$268.82K

―

-96.77%

―

PainReform

$0.99

$2.22M

-0.07

-87.83%

―

Dermata Therapeutics

$1.72

$3.84M

-0.18

-77.41%

1 Buy

0 Hold

0 Sell

Moderate Buy

Virax Biolabs Group Ltd. Class A

$2.91

$1.63M

-0.05

-91.84%

―

xxxxxxxxxxxxx

330 vs VRAX

xxxxxxxxxxxxx

Performance Comparison

DE:330

PhaseRx

―

SLRX

―

SCNI

Scinai Immunotherapeutics

0.47

-12.23

-96.29%

PRFX

PainReform

0.73

-5.07

-87.41%

DRMA

Dermata Therapeutics

0.78

-2.65

-77.34%

VRAX

Virax Biolabs Group Ltd. Class A

1.21

-12.34

-91.07%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >